Institution: IDIBELL – Bellvitge Institute for Biomedical Research / Catalan Institute of Oncology
Contact e-mail: miguelangel.pujana@gmail.com
Published: January 28th, 2022.
Deadline: February 28th, 2022.
Brief description: The Program Against Cancer Therapy Resistance (ProCURE) seeks to incorporate a tenure track investigator under the ISCIII-Miguel Servet Program. Applications from candidates from all areas of cancer research, including cancer genomics, computational biology, medical chemistry, computational modeling and drug development are encouraged. Salary will follow the Miguel Servet Program guidelines. Salary top up and start up package will be negotiated in relation to experience.
@procureico